These findings for the first time demonstrate the functional interaction of increased IL-15 concentrations in the peripheral blood and poor OS and DFS, regardless of the CTC status, lymph node metastasis, or hormone receptor status. This evidence concerns the gene IL15 and metastatic malignant neoplasm in the lymph nodes.